Vidya Bharathi Suraksha - Due diligence report

A 360° intelligence report on Vidya Bharathi Suraksha: trust score, financial health, credit view, compliance, directors, growth and distres…

2009-06-10 Bangalore, Karnataka Active Unlisted Active Compliant
Connect MCP
VB Vidya Bharathi Suraksha
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vidya Bharathi Suraksha — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Vidya Bharathi Suraksha is assessed as Low Risk with a Trust Score of 83/100. Vidya Bharathi Suraksha is an active private not for profit company incorporated in 2009, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 08 Aug 2026 from the latest processed filings. Vidya Bharathi Suraksha snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SRINIVASAN KRISHNAN 01234567 Director 01/04/2018 6 yrs Approved
MURALI ANANTHASUBRAMANIAN PATHAI 01234567 Director 01/04/2018 6 yrs Approved
GOWRISHANKAR VELLORE RAMACHANDRASASTRY 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
2
Group entities
2
Capital events
0 allotment(s) · 4 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Cancyte Technologies Private Limited Subsidiary Company 74.00%
Sri Research For Tissue Engineering Private Limited Subsidiary Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 75
Growth signals & trust indicators
Operating for 17+ years.
Distress signals & risk flags
Revenue declined year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view61/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
31 Dec 2020
Director ceased
MURALI ANANTHASUBRAMANIAN PATHAI
18 Nov 2020
Director appointed
MURALI ANANTHASUBRAMANIAN PATHAI (Director)
31 Mar 2020
Share transfer (FY 2020)
100.00000000 shares to MURALI ANANTHASUBRAMANIAN PATHAI
31 Mar 2019
Share transfer (FY 2019)
100.00000000 shares to Kamala Hariharan
18 Mar 2019
Director ceased
ARIYANAYAKIPURAM RAMASWAMY IYER HARIHARAN
31 Mar 2016
Share transfer (FY 2016)
10.00000000 shares to A R Hariharan
31 Mar 2015
Share transfer (FY 2015)
10.00000000 shares to ANAND
09 Apr 2010
Director appointed
SRINIVASAN KRISHNAN (Director)
10 Jun 2009
Incorporated
Registered with Roc Bangalore
Director appointed
GOWRISHANKAR VELLORE RAMACHANDRASASTRY (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Jh Rehabilitation Private Limited U85300TN2020PTC135047 Ambattur, Tamil Nadu, India
Uds Healthcare Private Limited U85190MH2022PTC379108 Panvel, Maharashtra, India
M R Dental (India) Private Limited U33112DL2001PTC111628 Shahdara, Delhi, India
Evander Hospital Private Limited U85110BR2021PTC054836 Patna, Bihar, India
Ayush Critical Care Private Limited U85191PN2013PTC149987 Pune, Maharashtra, India
Medinostics Lifesciences Private Limited U85100KA2021PTC152655 Bangalore, Karnataka, India
Continental Pellets Pharma Private Limited U85100TG2020PTC139385 Shaikpet, Telangana, India
Macline Four Solutions Private Limited U24110DL2022PTC397705 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vidya Bharathi Suraksha before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vidya Bharathi Suraksha: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Vidya Bharathi Suraksha - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Vidya Bharathi Suraksha pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Vidya Bharathi Suraksha - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vidya Bharathi Suraksha an active company?

Vidya Bharathi Suraksha has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Vidya Bharathi Suraksha financially healthy?

Vidya Bharathi Suraksha has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Vidya Bharathi Suraksha?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vidya Bharathi Suraksha?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Vidya Bharathi Suraksha have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Vidya Bharathi Suraksha up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Vidya Bharathi Suraksha?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.